Workflow
INKON Life(300143)
icon
Search documents
盈康生命(300143) - 盈康生命调研活动信息
2022-11-23 06:58
证券代码:300143 证券简称:盈康生命 盈康生命科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |----------------|-----------------------------|------------------------------------------------------| | | | | | 投资者关系活动 | □ 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | £ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | R 其他 (电话会议) | | | 参与单位名称及 | 华泰证券股份有限公司 沈卢庆 | | | 人员姓名 | | 上海睿郡资产管理有限公司 魏志华 | | | 上海睿亿投资发展中心 | ( 有限合伙) 许峰 | | | | 上海重阳投资管理股份有限公司 方溢涵 | | | 中信证券股份有限公司 罗啦 | | | 时间 | 2021 年 1 月 29 | 日 | | 地点 | 电话会议 | | | 上市公司接待人 | | | | 员姓名 | 董事会秘书 胡园园 ...
盈康生命(300143) - 盈康生命调研活动信息(2)
2022-11-22 04:38
证券代码:300143 证券简称:盈康生命 盈康生命科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |----------------|------------------------------|--------------------------------------------------------| | | | | | 投资者关系活动 | □ 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | ☑ 其他 (电话会议) | | | 参与单位名称及 | | 本次电话会议由华泰证券组织召开,投资者名单由华泰证券提 | | 人员姓名 | | 供,包括富国基金、睿远基金、嘉实基金、东方证券、中信证 | | | | 券、方正证券、泰康资产、华泰资管、光大保德信资管、睿郡 | | | | 投资、易正朗投资、景泰投资、寻常(上海)投资管理有限公 | | | | 司、中科沃土基金管理有限公司等二十余名机构投资者。 | | 时间 | 2021 年 4 月 30 日 ...
盈康生命(300143) - 盈康生命2021年6月3日-4日调研活动信息(一)
2022-11-22 03:10
1 证券代码:300143 证券简称:盈康生命 盈康生命科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-----------------------------|-----------------------------------------------------|--------------------------------------------------------------| | | | | | 投资者关系活动 | □ 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | 现场参观 | | | | 其他 (参加华泰证券 | 2021 年度中期投资峰会,并组织投 | | | 资者调研四川友谊医院) | | | 参与单位名称及 | 参加华泰证券 2021 | 年度中期投资峰会,以及华泰证券组织投 | | 人员姓名 | 件清单。 | 资者调研四川友谊医院,投资者名单由华泰证券提供,详见附 | | 时间 | 2021 年 6 月 3 日 2021 年 6 月 4 | 华泰证券 2 ...
盈康生命(300143) - 盈康生命调研活动信息
2022-11-22 03:10
证券代码:300143 证券简称:盈康生命 盈康生命科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-------------------------|--------------------------|--------------------------------------------------------| | | | | | 投资者关系活动 | □ 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | ☑ 现场参观 | | | | □ 其他 | | | 参与单位名称及 人员姓名 | | 分析师和投资者调研四川友谊医院,名单详见附件清单。 | | | | | | 时间 | 2021 年 5 月 20 日 | | | 地点 | 成都市锦江区上沙河铺街 | 96 号四川友谊医院 | | 上市公司接待人 | 四川友谊医院院长 | 王晋川 | | 员姓名 | 证券事务代表 | 吴露珠 | | | 一、友谊医院现场参观 | | | | | 主要参观了医院急诊科室、放疗科室、互联网医院 ...
盈康生命(300143) - 盈康生命2021年6月3日-4日调研活动信息(二)
2022-11-22 03:10
证券代码:300143 证券简称:盈康生命 盈康生命科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-----------------------|--------------------------------------|---------------------------------------------------------------------------------------------------------------| | | | | | 投资者关系活动 | □ 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 其他 (中信证券 | 2021 年资本市场论坛 & 东方证券 2021 年 | | | 度策略会) | | | 参与单位名称及 | 参加中信证券 2021 | 年资本市场论坛&东方证券 2021 年度策略 | | 人员姓名 | | 会,面向中信证券及东方证券邀请的投资者,包括诺德基金、 | | | | 立龙资产、于翼资产、景领投资、昆仑资 ...
盈康生命(300143) - 盈康生命调研活动信息(1)
2022-11-22 03:02
证券代码:300143 证券简称:盈康生命 盈康生命科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |----------------|------------------------------------------|--------------------------------------------------------| | | | | | 投资者关系活动 | ☑ 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ 其他 | | | 参与单位名称及 | 东兴证券股份有限公司 胡博新 | | | 人员姓名 | 华泰资产管理有限公司 王金成 | | | | 同泰基金管理有限公司 邢连云 | | | | 鹏扬基金管理有限公司 严定安 | | | | 长城财富保险资产管理股份有限公司 王政眸 | | | | 上海六禾投资有限公司 戴斌 | | | 时间 | 2021 年 4 月 29 日 | | | 地点 | 山东省青岛市崂山区海尔路 | 1 号海 ...
盈康生命(300143) - 盈康生命调研活动信息
2022-11-21 16:20
Company Overview - Yingkang Life Technology Co., Ltd. was established in 1998 and listed on the Shenzhen Stock Exchange in December 2010 with stock code 300143 [2] - The company has transformed into a leading provider of comprehensive services for tumor radiation therapy and medical services in China [2][3] Strategic Positioning - In July 2019, the company changed its name to Yingkang Life Technology Co., Ltd., marking a new strategic direction focused on integrated solutions for tumor treatment and rehabilitation [3] - The company aims to develop a comprehensive ecosystem around tumor treatment, emphasizing both high-end radiation therapy equipment and medical services [3] Business Development - The medical device segment is advancing towards high-end development, expanding from a single product (Gamma Knife) to a full range of radiation therapy equipment, including linear accelerators and integrated head-body knives [3] - The medical service segment is expanding its breadth, aiming to establish a one-stop medical service brand for tumor treatment, with a strategic goal of creating 10 flagship medical centers, 30 satellite hospitals, and 60 experience centers across the country [3] Hospital Network and Capacity - The company currently operates 4 hospitals with a total of 1,170 open beds: Sichuan Friendship Hospital (600 beds), Chongqing Youfang Hospital (300 beds), Hangzhou Yikang Hospital (120 beds), and Changchun Yingkang Hospital (150 beds) [4] - Plans are in place to expand bed capacity, with Sichuan Friendship Hospital aiming to increase its bed count to 800 within 2-3 years [4] Market Opportunities - The aging population and increasing demand for cancer care present significant market opportunities, with a growing burden of cancer and insufficient early screening rates [7] - The company is positioned to fill the demand gap in the tumor treatment market, leveraging government support and policies that enhance patient access to treatment [7] Future Plans - The company is focused on a "1+N+n" strategy, aiming to establish flagship medical centers in five major economic regions by early 2021 [7] - Plans include creating an integrated online and offline tumor treatment and rehabilitation experience platform to enhance patient access to high-quality medical resources [7]
盈康生命(300143) - 盈康生命调研活动信息
2022-11-21 16:20
Financial Performance - The company achieved a total revenue of 299 million CNY in the first half of 2021, representing a year-on-year growth of 3% [2] - Net profit reached 29.24 million CNY, with a year-on-year increase of 3% [2] - Total assets as of June 30, 2021, amounted to 2.67 billion CNY, up 30% year-on-year [2] - Net assets were reported at 2.21 billion CNY, reflecting a 59% year-on-year growth [2] - The asset-liability ratio decreased to 44.5%, indicating improved asset quality [2] Medical Services Segment - The medical services segment generated revenue of 277.29 million CNY, with a year-on-year growth of 37% [3] - Net profit in this segment increased by 32% year-on-year [3] - Outpatient visits rose by 79%, while inpatient admissions grew by 17% [3] - The hospital's outpatient revenue surged by 477% year-on-year, highlighting brand effectiveness [3] - The company focused on enhancing patient experience through a "1+N" service model, providing comprehensive medical services [4] Medical Equipment Segment - The medical equipment segment saw a significant revenue increase of 174% year-on-year [8] - The company is expanding its product offerings, focusing on high-end medical devices [6] - Research and development expenses totaled 12.69 million CNY, a 48.59% increase compared to the previous year [6] - The company signed contracts for 4 Gamma Knife units and 3 other medical devices, with revenue confirmation for 1 Gamma Knife unit [9] Strategic Initiatives - The company is enhancing its management capabilities through a standardized operational framework [11] - It aims to replicate its management model across various hospitals, focusing on tumor treatment and rehabilitation [6] - The strategic focus is on integrating medical resources and improving asset quality [6] - The company is actively pursuing mergers and acquisitions to expand its hospital network [12] Digital Transformation - The company is investing in digital platforms to improve operational efficiency and patient experience [11] - A digital management platform is being developed to unify hospital information systems and enhance service delivery [11] - The integration of IoT solutions aims to provide real-time monitoring and predictive maintenance for medical equipment [8]
盈康生命(300143) - 盈康生命调研活动信息
2022-11-21 16:12
证券代码:300143 证券简称:盈康生命 盈康生命科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |----------------|-----------------------------|--------------------------------------------------------| | | | | | 投资者关系活动 | 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | 其他 (电话会议) | | | | | | | 参与单位名称及 | 特定对象调研有:长江证券 | 伍云飞、诺德基金 陈少波、东吴 | | 人员姓名 | 资管 陆一韬、长盛基金 | 程文文、德邦基金 捷诗琪、东方基 | | | 金 王然、国寿安保基金 | 刘志军、国海富兰克林 刘牧、青岛 | | | 旭健投资 庞东、德邦资本 | 郝晓婧、长青基业 蔡承霖、海螺 | | | 创业 吴文博; | | | | | 本次电话会议由天风证券组织召开,投资者名单由天风证券提 | ...
盈康生命(300143) - 盈康生命2021年7月15日、16日调研活动信息
2022-11-21 16:06
证券代码:300143 证券简称:盈康生命 盈康生命科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |-----------------------------|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | 投资者关系活动 | 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ 其他 | | | 参与单位名称 ...